MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Effects of Physiotherapy on Mood Disorders in Patients with MSA, PSP, and PD

ET. Schoenfeldt-Reichmann, V. Sidoroff, H. Moradi, G. Prigent, S. Sapienza, F. Jagusch, I. Tackenburg, M. Asalian, N. Hergenroeder-Lenzner, M. Giraitis, J-P. Ndayisaba, G. Goebel, K. Seppi, A. Ionescu, F. Krismer, J. Winkler, B. Eskofier, J. Klucken, K. Aminian, G. Wenning, H. Gassner, C. Raccagni, D. Benninger (Lausanne, Switzerland)

Meeting: 2025 International Congress

Keywords: Non-motor Scales, Parkinson’s, Parkinsonism

Category: Parkinson's Disease: Non-Motor Symptoms (non-Cognitive/ non-Psychiatric)

Objective: To investigate the impact of physiotherapy on mood disorders such as apathy, anxiety, and depression in patients with Parkinson’s disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP), and whether mood improvement correlates with increased physical activity and better motor function.

Background: PD, MSA, and PSP are neurodegenerative diseases primarily marked by motor symptoms. However, mood disorders, like apathy, depression and anxiety, are prevalent and associated with increased frailty and disability, rapid functional decline and increased mortality1–4. Increasing evidence supports the efficacy of physiotherapy and exercise in improving motor and cognitive function which complement the pharmacological therapy5–8.

Method: This project is part of the Mobility_APP-Study, a multicenter, randomized, controlled, double-blind interventional study, comparing two approaches of physiotherapy. The intervention consists of a 2-week daily in-patient physiotherapy session followed by 5 weeks of home-based training. The assessment includes motor and cognitive testing, questionnaires, an Instrumented Gait Analysis (IGA) and a 1-week sensor-based monitoring of physical activity at baseline and study end.

Results: We enrolled 72 PD patients, 51 patients with PSP and 44 with MSA.

Compared to PD, atypical PD (PSP&MSA) patients show worse cognition, mood and motor performance at baseline, and throughout the study. PSP patients globally improve in mood with the in-patient physiotherapy but then worsen, except for anxiety.

Depression improves in PD patients’ during home-training, whereas anxiety improves in MSA patients during inpatient physiotherapy.

All groups show significant improvement in UPDRS-II scores, with slight balance improvement (BBS) in MSA and PD patients and better postural stability and gait (PIGD) in patients with APD. MSA patients increase their moderate physical activity.

Globally, better mood correlates with better motor function. In contrast, anxiety appears to increase despite improvement in motor function in both MSA and PSP after inpatient physiotherapy.

Conclusion: Physiotherapy improves both motor symptoms and mood including apathy, anxiety and depression, which appear to be interlinked. This underlines the efficacy of non-pharmacological interventions in the treatment of patients with PD and APD.

References: 1. Hu WZ, Cao LX, Yin JH, et al. Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson’s disease and progressive supranuclear palsy. Front Neurol. 2023;13:1081219. doi:10.3389/fneur.2022.1081219
2. Chen JJ, Marsh L. Anxiety in Parkinson’s disease: identification and management. Ther Adv Neurol Disord. 2014;7(1):52-59. doi:10.1177/1756285613495723
3. Wu T, Wang L, Chen Y, Zhao C, Li K, Chan P. Changes of functional connectivity of the motor network in the resting state in Parkinson’s disease. Neurosci Lett. 2009;460(1):6-10. doi:10.1016/j.neulet.2009.05.046
4. Farajzadeh A, Hébert A, Lahart IM, Bilodeau M, Boisgontier MP. Apathy and Physical Activity: A Systematic Review and Meta-Analysis. Published online May 3, 2024. doi:10.1101/2024.05.01.24306712
5. Cusso ME, Donald KJ, Khoo TK. The Impact of Physical Activity on Non-Motor Symptoms in Parkinson’s Disease: A Systematic Review. Front Med. 2016;3. doi:10.3389/fmed.2016.00035
6. Smith PJ, Merwin RM. The Role of Exercise in Management of Mental Health Disorders: An Integrative Review. Annu Rev Med. 2021;72(1):45-62. doi:10.1146/annurev-med-060619-022943
7. Ahern L, Curtin C, Timmons S, Lamb SE, McCullagh R. “Exercise… to Me, It’s Freedom”: Motivation, Support, and Self-Management to Keep Physically Active with Parkinson’s Disease: A Qualitative Study. Geriatrics. 2024;9(4):92. doi:10.3390/geriatrics9040092
8. Wu PL, Lee M, Huang TT. Effectiveness of physical activity on patients with depression and Parkinson’s disease: A systematic review. Lebedev MA, ed. PLOS ONE. 2017;12(7):e0181515. doi:10.1371/journal.pone.0181515

To cite this abstract in AMA style:

ET. Schoenfeldt-Reichmann, V. Sidoroff, H. Moradi, G. Prigent, S. Sapienza, F. Jagusch, I. Tackenburg, M. Asalian, N. Hergenroeder-Lenzner, M. Giraitis, J-P. Ndayisaba, G. Goebel, K. Seppi, A. Ionescu, F. Krismer, J. Winkler, B. Eskofier, J. Klucken, K. Aminian, G. Wenning, H. Gassner, C. Raccagni, D. Benninger. Effects of Physiotherapy on Mood Disorders in Patients with MSA, PSP, and PD [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/effects-of-physiotherapy-on-mood-disorders-in-patients-with-msa-psp-and-pd/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/effects-of-physiotherapy-on-mood-disorders-in-patients-with-msa-psp-and-pd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley